SCHEMBL31686944

CC[C@H](C)[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](C)N)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)O)C(C)C

nearest known ligand 0.68

Predicted protein targets (top 6)

	gene	UniProt	supporting neighbours	confidence
▸	RXFP1	Q9HBX9	2/20	0.68

▸	GLP1R	P43220	14/20	0.64

▸	ECE1	P42892	1/20	0.64

▸	MUS81	Q96NY9	1/20	0.64

▸	PTH1R	Q03431	3/20	0.63

▸	NPBWR1	P48145	1/20	0.62

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compound	similarity	top predicted	shared targets
SCHEMBL30183209	0.97	RXFP1 (0.68)	RXFP1GLP1RECE1MUS81PTH1R
SCHEMBL30271992	0.97	RXFP1 (0.68)	RXFP1GLP1RECE1MUS81PTH1R
SCHEMBL30038811	0.97	RXFP1 (0.72)	RXFP1GLP1RECE1MUS81PTH1R
SCHEMBL30844669	0.97	RXFP1 (0.69)	RXFP1GLP1RECE1MUS81PTH1R
SCHEMBL29848900	0.96	RXFP1 (0.67)	RXFP1GLP1RECE1MUS81PTH1R
SCHEMBL30049211	0.96	RXFP1 (0.66)	RXFP1GLP1RECE1MUS81PTH1R
SCHEMBL30598187	0.95	RXFP1 (0.66)	RXFP1GLP1RECE1MUS81PTH1R
SCHEMBL31093453	0.95	RXFP1 (0.69)	RXFP1GLP1RECE1MUS81PTH1R
SCHEMBL30446094	0.95	RXFP1 (0.70)	RXFP1GLP1RECE1MUS81PTH1R
SCHEMBL31087271	0.94	RXFP1 (0.68)	RXFP1GLP1RECE1MUS81PTH1R

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

Patent	Title	Assignee	Published	Priority	Filing	Country	Status
US-12419897-B2	Synthetic derivatives of cholic acid 7-sulfate and uses thereof	PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US)	2025-09-23	—	—	US	disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

Patent	Title	Text reads most about	Predicted target · text-rank
US-12419897-B2	Synthetic derivatives of cholic acid 7-sulfate and uses thereof	CYP7A1, NR1H4, CYP7B1	RXFP1 1112/4885GLP1R 168/4885ECE1 3143/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.